This meeting took place in 2017

Here are the related meetings in 2019:
Epigenetics and Human Disease (X5)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Epigenetics and Human Disease: Progress from Mechanisms to Therapeutics (A9)

Organizer(s) Johnathan R. Whetstine, Jessica K. Tyler and Rab K. Prinjha
January 29—February 2, 2017
Sheraton Seattle Hotel • Seattle, Washington USA
Discounted Abstract Deadline: Sep 29, 2016
Abstract Deadline: Oct 27, 2016
Scholarship Deadline: Sep 29, 2016
Discounted Registration Deadline: Nov 30, 2016

Sponsored by Incyte Corporation, Merck & Co., Inc., Taylor & Francis and Vertex Pharmaceuticals Incorporated

Summary of Meeting:
Epigenetics impacts human health and disease. Data from a range of diseases (cancer, neurological and immunological disorders) have documented mutations, altered expression and copy number alterations in numerous epigenetic factors (histones, DNA and chromatin modifying enzymes, reader proteins, chromatin modulators and noncoding RNAs). Genome-wide data has also illustrated the relationship between altered epigenetic states (e.g., modified DNA and histones) and disease onset and progression. Therefore, there is a need to discover the molecular mechanisms and interplay between epigenetic regulators. These mechanistic insights will shed light on the impact epigenetic regulators have on cellular homeostasis, while resolving their pathogenic contribution to disease states. This meeting is aimed at interrogating the most current knowledge surrounding the epigenetic events modulating nuclear function (gene expression regulation, enhancer modulation, domains and structural organization as well as cell division and differentiation), while relating this to developmental and disease models. In addition, this meeting will highlight the impact that preclinical and clinical epigenetic therapeutics have on a panel of diseases including cancer and neurological disorders. By presenting these various aspects associated with epigenetics and diverse disease, this unique forum should promote dynamic discussions, interactions and collaborations that will impact our understanding of disease and possible treatment strategies. Opportunities for trainee career development, networking and oral presentations are provided by a “Focus on Junior Scientists” session, a panel discussion and mixer with scientific editors and another with industry scientists.

View Meeting Program


Biogen ECITA Scholarship Recipients

Alika K. Maunakea
University of Hawaii, Manoa, USA

Keystone Symposia Future of Science Fund Scholarship Recipients

Anna Chiarella
University of Pennsylvania, USA

Liam Niall Gilding
University of Birmingham, UK

Robert Hansel-Hertsch
University of Cambridge, UK

Efrat Shema
Massachusetts General Hospital, USA